- Disease: Monkeypox virus infection
- Study type: Observational Cohort Study
- Study type descriptors: Prospective, Retrospective, Multicentre
- Study aim: To describe the clinical and virologic characteristics and outcomes of participants with laboratory-confirmed mpox, treated and not treated with tecovirimab or other antiviral drugs
- Number of participants enrolled: 619
- Study enrolling from to
- Study includes follow-up for 6 months
Study Data
- Adults
- General population
- Hospital wide
- Outpatient clinic
- STD/STI clinic
- Monkeypox virus
- Monkeypox virus infection
- Blood sample
- Nasopharyngeal swab
- Skin lesion swab
External Links
Other information
Funders:
- Wellcome (215091/Z/18/Z)
- Bill and Melinda Gates Foundation (OPP1209135)
- MPX-Response (101115188) – Horizon Europe
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to